Ventyx Biosciences Inc header image

Ventyx Biosciences Inc

VTYX

Equity

ISIN US92332V1070 / Valor 114064386

NASDAQ (2024-11-20)

USD 1.72-3.37%

Ventyx Biosciences Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company specializing in the development of novel oral therapies for patients with autoimmune and inflammatory disorders. The company's pipeline includes various promising drug candidates such as VTX958, VTX002, VTX2735, and VTX3232, targeting different mechanisms to address a broad range of autoimmune diseases. Ventyx is dedicated to advancing innovative treatments to improve the lives of patients suffering from these debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-27.1%1Y

-92.1%3Y

%5Y

Performance

118%1Y

138%3Y

137%5Y

Volatility

830 M

Market cap (USD)

411,684

Daily traded volume (Shares)

1.815 / 1.72

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Conmed Corp

Conmed Corp Valor: 920278

Annual Return

-50%0%+50%

Risk level

110

-1.48%USD 70.69

Bausch Health Companies Inc

Bausch Health Companies Inc Valor: 42260834

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 8.19

Novartis Inc

Novartis Inc Valor: 1200526

Annual Return

-50%0%+50%

Risk level

110

-0.08%CHF 90.99

Amgen Inc

Amgen Inc Valor: 907582

Annual Return

-50%0%+50%

Risk level

110

2.83%USD 287.87

Dexcom Inc

Dexcom Inc Valor: 2107726

Annual Return

-50%0%+50%

Risk level

110

0.48%USD 75.24

Illumina Inc

Illumina Inc Valor: 1111080

Annual Return

-50%0%+50%

Risk level

110

-2.46%USD 131.68

Roche Holding Ltd

Roche Holding Ltd Valor: 1203211

Annual Return

-50%0%+50%

Risk level

110

-0.68%CHF 264.40

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

2.88%USD 84.90

BeiGene Ltd

BeiGene Ltd Valor: 30165310

Annual Return

-50%0%+50%

Risk level

110

3.46%USD 194.26

Hologic Inc

Hologic Inc Valor: 939263

Annual Return

-50%0%+50%

Risk level

110

-0.67%USD 78.04

SIX

FactSet

Clearbit

Logos provided by Clearbit